Skip to main content
FinSpry Logo
FinSpry
MESO logo
MESO
(NASDAQ)
Mesoblast Limited
$16.39-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Mesoblast (MESO) Stock Price & Financial Analysis

Mesoblast Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$16.39 - $16.72
52-Week High$21.50
52-Week Low$13.05
Open$16.71
Volume151.21K
Average Volume (3M)190.84K
Market Cap2.24B
Shares Outstanding129.20M
Price to Sales (P/S)130.12
Price to Book (P/B)3.89
EV/EBITDA-38.42
Revenue (TTM)17.20M
Net Income (TTM)-102.14M
Free Cash Flow (TTM)-49.11M
EPS (TTM)$-0.85
Profit Margin-593.92%
Operating Margin-639.46%
Return on Equity (ROE)-17.77%
Debt to Equity0.22
50-Day MA$15.99
200-Day MA$16.12
52-Week Change12.65%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Mesoblast

What is the current stock price for MESO?

As of the latest trading session, MESO stock trades at $16.39. The 52-week range is $13.05–$21.50, with a day range of $16.39–$16.72.

What is the P/E ratio for MESO?

The P/E ratio (Price-to-Earnings) for MESO is shown in the Key Statistics section. This valuation metric helps compare Mesoblast Limited to industry peers.

Does MESO pay dividends?

Mesoblast does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MESO?

Based on 1 analyst, the consensus for MESO is Hold.

What is the market cap of MESO?

Mesoblast's market capitalization is $2.12B, classifying it as a mid-cap company. Mesoblast operates in the Healthcare sector within the Biotechnology industry.